The decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.

Antibiotic-resistant bacteria are a serious public health threat. Understanding the biology of these bacteria—such as how ...

Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and ...

SINGAPORE: Antibiotic-resistant bacteria pose a significant threat to public health, and researchers from the Yong Loo Lin School of Medicine at the National Un ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria -- such as how they synthesise their ...

US pharma giant Merck & Co (NYSE: MRK) today announced that the European Commission (EC) has approved Capvaxive (Pneumococcal ...

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

Objective: To compare the safety and efficacy of clarithromycin and amoxicillin/clavulanic acid in patients with community-acquired pneumonia due to penicillin ...

In reality, pneumococcal pneumonia, caused by the Streptococcus pneumoniae bacteria, is a life-threatening lung infection that can strike suddenly and escalate rapidly. Lung Foundation of Malaysia ...